IP Library Granted Patent US 12,018,295
Granted Patent B2
US 12,018,295 · App. 17/345,404 · Granted Jun 25, 2024

Engineered DNA polymerase variants

Inventors: Mathew G. Miller (San Carlos, CA); Vesna Mitchell (Santa Clara, CA); Jovana Nazor (Milpitas, CA); Donald S. Baskerville (Louisville, CO); Nikki Dellas (San Carlos, CA); David Elgart (San Mateo, CA); Jonathan Vroom (South San Francisco, CA); Sandy M. Gomes (Redwood City, CA); Nandhitha Subramanian (Cambridge, GB); Ericka Bermudez (Aptos, CA)
Assignee: Codexis, Inc.
C12N9/1252
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,018,295
App. No.
17/345,404
Filed
Jun 11, 2021
Granted
Jun 25, 2024
Kind
B2
Art Unit
1652
USPC
435/194
Abstract

The present invention provides engineered DNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered DNA polymerase polypeptides. The invention also provides methods for use of the compositions comprising the engineered DNA polymerase polypeptides for diagnostic and other purposes.

Claims (14)

1. A polynucleotide comprising a polynucleotide sequence encoding an engineered DNA polymerase comprising a polypeptide sequence having at least 85% or more sequence identity to the reference sequence of SEQ ID NO: 6, wherein the polypeptide sequence comprises at least a substitution at amino acid position 515, wherein the amino acid positions are numbered with reference to SEQ ID NO: 6.

2. The polynucleotide of claim 1 , wherein said polynucleotide sequence encodes an engineered DNA polymerase comprising a polypeptide sequence having at least 0% or more sequence identity to the reference sequence of SEQ ID NO: 6.

3. The polynucleotide of claim 1 , wherein said polynucleotide sequence is operably linked to a control sequence.

4. The polynucleotide of claim 1 , wherein said polynucleotide sequence is codon-optimized.

5. An expression vector comprising a polynucleotide of claim 1 .

6. A host cell an expression vector of claim 5 .

7. A method of producing an engineered DNA polymerase polypeptide in a host cell, comprising culturing a host cell of claim 6 , under suitable culture conditions such that said engineered DNA polymerase is produced.

8. The method of claim 7 , further comprising recovering at least one engineered DNA polymerase from the culture and/or host cells.

9. The method of claim 8 , further comprising the step of purifying said engineered DNA polymerase.

10. The polynucleotide of claim 1 , wherein said polynucleotide sequence encodes an engineered DNA polymerase comprising a polypeptide sequence having at least 91%, 92%, 93%, or 94% or more sequence identity to the reference sequence of SEQ ID NO: 6.

11. The polynucleotide of claim 1 , wherein said polynucleotide sequence encodes an engineered DNA polymerase comprising a polypeptide sequence having at least 95%, 96%, 97%, or 98% or more sequence identity to the reference sequence of SEQ ID NO: 6.

12. The polynucleotide of claim 1 , wherein said polynucleotide sequence encodes an engineered DNA polymerase comprising a polypeptide sequence having at least 99% or more sequence identity to the reference sequence of SEQ ID NO: 6.

13. The polynucleotide of claim 1 , wherein the substitution at amino acid position 515 comprises substitution 515F, 515G, 515L, or 515R.

14. The polynucleotide of claim 1 , wherein the substitution at amino acid position 515 comprises substitution 515L.